deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT03440125

Cayenne Pepper Cataplasm - Safety Study (Munari04)

Cayenne Pepper Cataplasm Application and Potential Side Effects

Sponsor: Comenius University

Conditions Low Back Pain
Updated 6 times since 2018 Last updated: Feb 19, 2018 Started: Mar 15, 2016 Primary completion: Nov 15, 2016 Completion: Dec 15, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Low Back Pain, this trial is completed. The trial is conducted by Comenius University and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotCompleted~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jun 2018 — Dec 2018 [monthly]

    Completed PHASE1_PHASE2

Show 1 earlier version
  1. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Comenius University
  • Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation
  • S2P, Science to Practice, Ltd.
  • University of Primorska
  • Wilhelminenspital Vienna
Data source: University of Primorska

For direct contact, visit the study record on ClinicalTrials.gov .